Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2009 2
2010 2
2011 4
2012 2
2013 4
2014 10
2015 7
2016 9
2017 13
2018 10
2019 10
2020 12
2021 10
2022 8
2023 1
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Globus Lucidus: A porcine study of an intracranial implant designed to deliver closed, repetitive photodynamic and photochemical therapy in glioblastoma.
Bader N, Peschmann C, Kast RE, Heiland T, Merz T, McCook O, Alfieri A, Karpel-Massler G, Capanni F, Halatsch ME. Bader N, et al. Among authors: karpel massler g. Photodiagnosis Photodyn Ther. 2024 Mar 27;46:104059. doi: 10.1016/j.pdpdt.2024.104059. Online ahead of print. Photodiagnosis Photodyn Ther. 2024. PMID: 38548041 Free article.
OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma.
Nguyen TT, Torrini C, Shang E, Shu C, Mun JY, Gao Q, Humala N, Akman HO, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Nguyen TT, et al. Among authors: karpel massler g. JCI Insight. 2024 Mar 14;9(8):e172565. doi: 10.1172/jci.insight.172565. JCI Insight. 2024. PMID: 38483541 Free article.
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Cao Q, Hajosch A, Kast RE, Loehmann C, Hlavac M, Fischer-Posovszky P, Strobel H, Westhoff MA, Siegelin MD, Wirtz CR, Halatsch ME, Karpel-Massler G. Cao Q, et al. Among authors: karpel massler g. Br J Cancer. 2024 May;130(8):1365-1376. doi: 10.1038/s41416-024-02608-8. Epub 2024 Feb 23. Br J Cancer. 2024. PMID: 38396172 Free PMC article.
Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma.
Nguyen TTT, Shang E, Westhoff MA, Karpel-Massler G, Siegelin MD. Nguyen TTT, et al. Among authors: karpel massler g. Cells. 2022 Sep 22;11(19):2956. doi: 10.3390/cells11192956. Cells. 2022. PMID: 36230918 Free PMC article. Review.
Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma.
Torrini C, Nguyen TTT, Shu C, Mela A, Humala N, Mahajan A, Seeley EH, Zhang G, Westhoff MA, Karpel-Massler G, Bruce JN, Canoll P, Siegelin MD. Torrini C, et al. Among authors: karpel massler g. Mol Cell. 2022 Aug 18;82(16):3061-3076.e6. doi: 10.1016/j.molcel.2022.06.030. Epub 2022 Aug 9. Mol Cell. 2022. PMID: 35948010 Free PMC article.
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen.
Kast RE, Alfieri A, Assi HI, Burns TC, Elyamany AM, Gonzalez-Cao M, Karpel-Massler G, Marosi C, Salacz ME, Sardi I, Van Vlierberghe P, Zaghloul MS, Halatsch ME. Kast RE, et al. Among authors: karpel massler g. Cancers (Basel). 2022 May 23;14(10):2563. doi: 10.3390/cancers14102563. Cancers (Basel). 2022. PMID: 35626167 Free PMC article.
100 results